Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Vestronidase Alfa

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ANVISA Approved New Drug to treat Sly syndrome
    ANVISA Approved New Drug to treat Sly syndrome

    21 Oct 2018

    // ANVISA

    http://portal.anvisa.gov.br/noticias?p_p_id=101_INSTANCE_FXrpx9qY7FbU&p_p_col_id=column-2&p_p_col_pos=1&p_p_col_count=2&_101_INSTANCE_FXrpx9qY7FbU_groupId=219201&_101_INSTANCE_FXrpx9qY7FbU_urlTitle=aprovado-novo-medicamento-para-tratar-a-sindrome-de-sly&_101_INSTANCE_FXrpx9qY7FbU_struts_action=%2Fasset_publisher%2Fview_content&_101_INSTANCE_FXrpx9qY7FbU_assetEntryId=5025741&_101_INSTANCE_FXrpx9qY7FbU_type=content

    ANVISA
    21 Oct 2018
    Share Share
    Ultragenyx Germany GmbH's Mepsevii (vestronidase alfa) Receives Approval in Europe
    Ultragenyx Germany GmbH's Mepsevii (vestronidase alfa) Receives Approval in Europe

    29 Aug 2018

    // EMA

    http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/004438/WC500254546.pdf

    EMA
    29 Aug 2018
    Share Share
    EU OKs first treatment for ultra rare lysosomal storage disorder
    EU OKs first treatment for ultra rare lysosomal storage disorder

    29 Aug 2018

    // Selina McKee PHARMA TIMES

    http://www.pharmatimes.com/news/eu_oks_first_treatment_for_ultra_rare_lysosomal_storage_disorder_1250598

    Selina McKee PHARMA TIMES
    29 Aug 2018
    Share Share
    Rentschler signs Ultragenyx fill/finish deal for US supply
    Rentschler signs Ultragenyx fill/finish deal for US supply

    01 Jun 2018

    // BIOPHARMA REPORTER

    https://www.biopharma-reporter.com/Article/2018/06/01/CMO-Rentschler-signs-Ultragenyx-fill-finish-deal-for-US-supply

    BIOPHARMA REPORTER
    01 Jun 2018
    Share Share